AU681919B2 - N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds - Google Patents

N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds

Info

Publication number
AU681919B2
AU681919B2 AU81038/94A AU8103894A AU681919B2 AU 681919 B2 AU681919 B2 AU 681919B2 AU 81038/94 A AU81038/94 A AU 81038/94A AU 8103894 A AU8103894 A AU 8103894A AU 681919 B2 AU681919 B2 AU 681919B2
Authority
AU
Australia
Prior art keywords
radionuclides
radio
compounds
processes
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU81038/94A
Other languages
English (en)
Other versions
AU8103894A (en
Inventor
Ludger Dinkelborg
Bernd Noll
Steffi Noll
Paul-Eberhard Schulze
Hartmut Spies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Institut fuer Diagnostikforschung GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut fuer Diagnostikforschung GmbH filed Critical Institut fuer Diagnostikforschung GmbH
Publication of AU8103894A publication Critical patent/AU8103894A/en
Application granted granted Critical
Publication of AU681919B2 publication Critical patent/AU681919B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/20Esters of monothiocarboxylic acids
    • C07C327/26Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57536Endothelin, vasoactive intestinal contractor [VIC]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0827Tripeptides containing heteroatoms different from O, S, or N

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU81038/94A 1993-11-01 1994-10-27 N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds Ceased AU681919B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4337600A DE4337600A1 (de) 1993-11-01 1993-11-01 N-Alkyl-Peptidchelatbildner, deren Metallkomplexe mit Radionukliden, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende radiopharmazeutische Zusammesetzungen
DE4337600 1993-11-01
PCT/DE1994/001295 WO1995012610A1 (de) 1993-11-01 1994-10-27 N-alkyl-peptidchelatbildner, deren metallkomplexe mit radionukliden, verfahren zu ihrer herstellung und diese verbindungen enthaltende radiopharmazeutische zusammensetzungen

Publications (2)

Publication Number Publication Date
AU8103894A AU8103894A (en) 1995-05-23
AU681919B2 true AU681919B2 (en) 1997-09-11

Family

ID=6501750

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81038/94A Ceased AU681919B2 (en) 1993-11-01 1994-10-27 N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds

Country Status (11)

Country Link
EP (1) EP0726909A1 (hu)
JP (1) JPH09508351A (hu)
KR (1) KR960705842A (hu)
CN (1) CN1134158A (hu)
AU (1) AU681919B2 (hu)
CA (1) CA2173844A1 (hu)
DE (1) DE4337600A1 (hu)
HU (1) HUT74881A (hu)
NO (1) NO961743D0 (hu)
WO (1) WO1995012610A1 (hu)
ZA (1) ZA948411B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
US6162378A (en) * 1999-02-25 2000-12-19 3D Systems, Inc. Method and apparatus for variably controlling the temperature in a selective deposition modeling environment
US6171578B1 (en) 1999-04-14 2001-01-09 Diatide, Inc. Benzodiazepine derivatives for imaging thrombi
CA2781858C (en) 2000-05-12 2015-03-31 Genzyme Corporation Modulators of tnf-.alpha. signaling

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811340B (en) * 1980-06-09 1982-03-31 Morton Norwich Products Inc N-(cycloalkyl)amino acid compounds
WO1992019274A1 (en) * 1991-05-08 1992-11-12 Mallinckrodt Medical, Inc. Technetium chelates to be used for determining the renal function
JPH0570484A (ja) * 1991-09-12 1993-03-23 Hitachi Chem Co Ltd ペプチドおよびその塩
JPH07503732A (ja) * 1992-02-06 1995-04-20 マリンクロッド・インコーポレイテッド 金属キレート形成速度を高めるためのリガンド類
JP2941057B2 (ja) * 1992-05-21 1999-08-25 ダイアテク,インコーポレイテッド 血栓造影用のテクネチウム‐99m標識ペプチド
DE4311021A1 (de) * 1993-03-31 1994-10-27 Diagnostikforschung Inst Bifunktionelle Chelatbildner, deren Technetium- und Rhenium-Komplexe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende radiopharmazeutische Mittel

Also Published As

Publication number Publication date
WO1995012610A1 (de) 1995-05-11
NO961743L (no) 1996-04-30
NO961743D0 (no) 1996-04-30
CA2173844A1 (en) 1995-05-11
HUT74881A (en) 1997-02-28
JPH09508351A (ja) 1997-08-26
AU8103894A (en) 1995-05-23
CN1134158A (zh) 1996-10-23
DE4337600A1 (de) 1995-05-04
KR960705842A (ko) 1996-11-08
HU9601140D0 (en) 1996-07-29
EP0726909A1 (de) 1996-08-21
ZA948411B (en) 1995-06-30

Similar Documents

Publication Publication Date Title
HU9600441D0 (en) Pharmaceutical compositions comprising metal complexes
EP0666238A4 (en) METAL OXIDE POWDER AND PROCESS FOR PRODUCING THE SAME.
AU2569292A (en) Powder metal alloy process
AU586831B2 (en) Metal complexes
HUP9801949A3 (en) Ternary radiopharmaceutical complexes
EP0666239A4 (en) METAL OXIDE COMPOSITE POWDER AND METHOD FOR PRODUCING THE SAME.
AU3778989A (en) Diaminedithiol chelating agents for radiopharmaceuticals
AU7384394A (en) Chelating compounds
GB8802788D0 (en) Composition & process for treating metal surfaces
AU8105491A (en) Process for the preparation of transition metal nitrido complexes
GB9006522D0 (en) Metal complexes
AU681919B2 (en) N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds
ZA938576B (en) Process for preparing 1,3-difluorobenzene
GB2218711B (en) Process for producing powdered inorganic compounds and metal compositions.
IL111817A0 (en) Halogen-containing metal complexes, diagnostic agents containing the same and processes for the preparation thereof
GB2272702B (en) A process for the preparation of aluminium-heavy metal mixed complexes
AU3072192A (en) Process for preparing uva-absorbing sunscreen metal complexes
AU6417296A (en) Compounds which can form complexes with metals
IL63928A0 (en) Beta-diketone metal complexes,processes for the preparation thereof and pharmaceutical compositions containing the same
AU8218582A (en) Addition agent for iron-base alloys
AU573216B2 (en) Metal amine complexes
IL110571A0 (en) Radiometal complexes
EP0792170A4 (en) METAL CHELATES OF RADIONUCLIDES USED FOR RADIOTARKING LIGANDS, ANTI-LIGANDS AND OTHER PROTEINS
AU4237493A (en) Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as radiopharmaceuticals
AU4239893A (en) Bicyclopolyazamacrocyclophosphonic acid complexes, a process for their preparation, and their conjugates, for use as radiopharmaceuticals

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired